ArticleReviews in cardiovascular medicine2026
Clinical Prognostic Impact of CALLY in Heart Failure Patients With Different Ejection Fractions: A Retrospective Study.
Article in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic heart failure (CHF) is closely linked to high morbidity and mortality rates, with inflammation and changes in nutritional status being key contributors to disease progression. Thus, this study aimed to evaluate the prognostic utility of the novel composite index CALLY, which incorporates albumin (ALB) level, lymphocyte count (LYM), and C-reactive protein (CRP) level, for predicting all-cause mortality in patients with CHF and varying ejection fractions. Methods: This retrospective cohort study included 1193 patients with CHF who were admitted to the First Affiliated Hospital of Kunming Medical University between January 2017 and October 2021. Restricted cubic spline analysis was used to determine the CALLY index cutoff value and classify patients into two groups. Kaplan-Meier and multivariable Cox regression analyses were performed to assess the prognostic value of CALLY in the overall cohort and in subgroups with HFrEF, HFmrEF, and HFpEF. Model performance was evaluated using receiver operating characteristic curves with DeLong's test, calibration curves with bootstrap resampling, and decision curve analysis. Results: Kaplan‒Meier analysis revealed that lower CALLY levels were associated with higher all-cause mortality in all patients with CHF and in the twoCHF subgroups. Multivariable Cox proportional hazards analysis demonstrated that CALLY independently predicted all-cause mortality across all heart failure subtypes. Receiver operating characteristic curve analysis indicated that models incorporating CALLY exhibited improved predictive performance. Calibration and decision curve analyses further supported the clinical utility of the CALLY index. Conclusions: Amongpatients with CHF in this cohort, a lower CALLY index was independently associated with higher all-cause mortality across different ejection fraction categories. These findings suggest that CALLY may serve as a potential risk marker.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.